Torrent Pharmaceuticals Limited — Important, 01-06-2026: Updates
01-06-2026 | 07:45 pm
01-06-2026 | 07:45 pm
Torrent Pharma submitted its FY25-26 BRSR, showcasing strong ESG performance and improved resource efficiency. The company incurred over ` 48 crore in fines from NPPA and GST authorities for various issues. Operational advancements and local sourcing initiatives continue.
No comments yet. Be the first to comment!
